Appleton Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,496
| Closed | -$645K | – | 303 |
|
|
2019
Q3 | $645K | Sell |
6,496
-1,523
| -19% | -$145K | 0.08% | 168 |
|
|
2019
Q2 | $741K | Sell |
8,019
-1,445
| -15% | -$137K | 0.09% | 159 |
|
|
2019
Q1 | $893K | Buy |
9,464
+2,173
| +30% | +$190K | 0.12% | 141 |
|
|
2018
Q4 | $467K | Sell |
7,291
-3,126
| -30% | -$231K | 0.07% | 178 |
|
|
2018
Q3 | $932K | Sell |
10,417
-274
| -3% | -$24.2K | 0.12% | 144 |
|
|
2018
Q2 | $849K | Sell |
10,691
-570
| -5% | -$47.3K | 0.12% | 151 |
|
|
2018
Q1 | $1M | Sell |
11,261
-301
| -3% | -$28.9K | 0.15% | 138 |
|
|
2017
Q4 | $1.21M | Sell |
11,562
-15
| -0.1% | -$1.69K | 0.19% | 126 |
|
|
2017
Q3 | $1.69M | Sell |
11,577
-485
| -4% | -$66.1K | 0.28% | 91 |
|
|
2017
Q2 | $1.57M | Buy |
12,062
+5,078
| +73% | +$622K | 0.26% | 94 |
|
|
2017
Q1 | $869K | Sell |
6,984
-2,244
| -24% | -$269K | 0.16% | 128 |
|
|
2016
Q4 | $1.07M | Sell |
9,228
-170
| -2% | -$18.9K | 0.22% | 109 |
|
|
2016
Q3 | $982K | Buy |
9,398
+949
| +11% | +$103K | 0.19% | 121 |
|
|
2016
Q2 | $833K | Sell |
8,449
-1,614
| -16% | -$167K | 0.17% | 113 |
|
|
2016
Q1 | $1.01M | Sell |
10,063
-21
| -0.2% | -$2.16K | 0.2% | 98 |
|
|
2015
Q4 | $1.21M | Buy |
10,084
+1,898
| +23% | +$220K | 0.24% | 90 |
|
|
2015
Q3 | $885K | Buy |
8,186
+1,500
| +22% | +$186K | 0.2% | 98 |
|
|
2015
Q2 | $774K | Sell |
6,686
-420
| -6% | -$48K | 0.17% | 102 |
|
|
2015
Q1 | $819K | Sell |
7,106
-94
| -1% | -$11.2K | 0.18% | 98 |
|
|
2014
Q4 | $805K | Buy |
7,200
+748
| +12% | +$78.9K | 0.18% | 96 |
|
|
2014
Q3 | $612K | Buy |
6,452
+140
| +2% | +$12.6K | 0.14% | 107 |
|
|
2014
Q2 | $542K | Buy |
6,312
+250
| +4% | +$19K | 0.13% | 119 |
|
|
2014
Q1 | $423K | Sell |
6,062
-600
| -9% | -$47.5K | 0.1% | 122 |
|
|
2013
Q4 | $563K | Buy |
6,662
+540
| +9% | +$42.7K | 0.14% | 101 |
|
|
2013
Q3 | $472K | Hold |
6,122
| – | – | 0.13% | 106 |
|
|
2013
Q2 | $358K | Buy |
+6,122
| New | +$368K | 0.1% | 106 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Appleton Partners's CELG Position: Q4 2019 in Review
Appleton Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,496 shares — an estimated $645K sold.
Appleton Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.69M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Appleton Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Appleton Partners sold 6,496 Celgene Corp shares in Q4 2019, an estimated $645K.
- Appleton Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Appleton Partners's Celgene Corp position peaked at $1.69M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Appleton Partners's 13F filing for Q4 2019, filed 13 Jan 2020.